Project Grant R01MH137527
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $1,453,943 to UCLA under the Mental Health Research Grants program (CFDA 93.242) beginning June 1, 2025 and concluding May 31, 2028. This R61/R33 project grant supports the development of an integrated, portable sensor suite designed to track attention states in natural environments by combining neural oscillation monitoring with physiological measurements and privacy-preserving sensing technology. The research...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $433,125 to the University of California, Los Angeles under the Mental Health Research Grants program (CFDA 93.242) on September 18, 2025, for a two-year project concluding September 17, 2027. This project grant funds basic neuroscience research investigating the asymmetrical development of Early B cell Factor 1 (EBF1)-expressing cells in the central amygdala and their functional consequences for emotion-related...
- Federal Grant Award Summary Docbotic Inc. received a $499,887 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective September 1, 2025, through August 31, 2026. The award funds development of BETTERBOT, an artificial intelligence-enabled Short Message Service (SMS) chatbot designed to deliver evidence-based behavioral activation therapy for individuals with Traumatic Brain Injury (TBI). The chatbot...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $1,476,008 Project Grant to The Regents of the University of California, San Francisco under the Mental Health Research Grants program (CFDA 93.242) effective March 1, 2025, with completion scheduled for December 31, 2029. This award supports fundamental neuroscience research investigating the neural circuits and population dynamics underlying associative learning in the ventral hippocampus. The research...
- Federal Grant Award Summary New York University received a $633,438 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) on June 16, 2025, with a completion date of March 31, 2030. The award supports research on data-driven control of primate prefrontal neural activity using patterned microstimulation. The project addresses a critical gap in neuroscience and neuroengineering by developing a data-driven framework for...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Leland Stanford Junior University a Project Grant totaling $744,121.00 under the Mental Health Research Grants program (CFDA 93.242) to develop foundation models (FMs) for human functional neuroimaging with applications to psychiatric disorders. The research, initiated on July 14, 2025, and scheduled for completion by April 30, 2030, aims to create an integrated framework combining foundation models with...
- Federal Grant Award Summary The University of Southern California received a $654,923 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) effective September 1, 2025, through June 30, 2030. The award supports the ENIGMA CentilebBrain initiative, an international normative modeling framework designed to establish standardized reference values for neuroimaging phenotypes across brain morphology, white matter...
- Federal Grant Award Summary The University of Chicago received a $410,000 project grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective July 1, 2025, through June 30, 2027. This exploratory research project develops and validates the use of intracranial electroencephalography (IEEG) to investigate how noninvasive brain stimulation modulates hippocampal neural activity and affects memory function. The research employs...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $336,935 to the University of California, Los Angeles under the 21st Century Cures Act – Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372) on August 1, 2025, with a completion date of July 31, 2027. This Project Grant supports the development of advanced neural recording techniques that combine dual in vivo whole-cell and large-scale...
- Federal Grant Award Summary Neuralthread Inc. received a $980,661 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) awarded on September 17, 2025, with a completion date of July 31, 2028. The company is developing TULLEKIT, an integrated deep brain neural recording system designed to enable stable, high-density neural recordings in freely moving non-human primates (NHPs). The system comprises three core components:...
The National Institute of Mental Health (NIMH) awarded $424,433 to the University of California, Los Angeles on March 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop practical frameworks and implementation tools for enhancing participant engagement in brain-computer interface (BCI) early feasibility studies. The project, titled "From Concepts to Tools: Improving Participant Engagement in Brain Computer Interface Early Feasibility Studies," will deliver two primary products: (1) a comprehensive framework for designing participant engagement practices in BCI early feasibility studies, and (2) an online tool to assist research teams in implementing this framework within their clinical trials. The project addresses a critical gap in the field, as BCI early feasibility studies involve implanted devices for individuals with severe motor or communication disabilities requiring brain surgery and years of intensive participation, yet existing guidance on participant engagement remains fragmented and lacks practical implementation standards. Conducted through December 31, 2029, this research initiative will systematically investigate participant engagement across disciplines and produce evidence-based guidance to maximize technology benefits for current and future BCI trial participants. The work is timely given increased industry interest in commercializing neurotechnology and aims to ensure that participant experiences, knowledge, and values inform the co-creation of BCI technology, ultimately determining whether these devices achieve sustainable clinical benefit for affected populations.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $424.4k | 2/12/26 |